NOS2 and neoplasm: Celecoxib in combination with IFNγ reduced the expression of MMP-2, MMP-9, and VEGF-A in tumor and decreased MVD, mediated by the increased amount of CD68+iNOS+ M1 macrophages and by decreased amount of CD68+Arg1+ M2 macrophages in mouse model of LLC [273].